The DOI matches its Crossref record; 232 of the 232 references it cites were found in a registry or an index.
Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis
Open accessAbstract
Parkinson's disease (PD) is a progressive neurodegenerative movement disorder with unknown etiology. It is marked by widespread neurodegeneration in the brain with profound loss of A9 midbrain dopaminergic neurons in substantia nigra pars compacta. Several theories of biochemical abnormalities have been linked to pathogenesis of PD of which mitochondrial dysfunction due to an impairment of mitochondrial complex I and subsequent oxidative stress seems to take the center stage in experimental models of PD and in postmortem tissues of sporadic forms of illness. Recent identification of specific gene mutations and their influence on mitochondrial functions has further reinforced the relevance of mitochondrial abnormalities in disease pathogenesis. In both sporadic and familial forms of PD abnormal mitochondrial paradigms associated with disease include impaired functioning of the mitochondrial electron transport chain, aging associated damage to mitochondrial DNA, impaired calcium buffering, and anomalies in mitochondrial morphology and dynamics. Here we provide an overview of specific mitochondrial functions affected in sporadic and familial PD that play a role in disease pathogenesis. We propose to utilize these gained insights to further streamline and focus the research to better understand mitochondria's role in disease development and exploit potential mitochondrial targets for therapeutic interventions in PD pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–232 of 232
Acute and persistent parkinsonism after use of diquat
Sechi, G. P., Agnetti, V., Piredda, M. L., Canu, M., Deserra, F., Omar, H. Α., & Rosati, G. (1992) · Neurology · doi:10.1212/wnl.42.1.261 · Cited by 74
Frei, B. B., & Richter, C. (1986) · FEBS Letters · doi:10.1016/0014-5793(86)81192-9 · Cited by 70
Thomas, B., von Coelln, R., Mandir, A. S., Trinkaus, D. B., Farah, M. H., Lim, K. L., Calingasan, N. Y., Beal, M. F., Dawson, V. L., & Dawson, T. M. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.12.021 · Cited by 70
Self-citationPlatelet mitochondrial respiratory chain function in Parkinson's disease
Blake, C. I., Spitz, E., Leehey, M. A., Hoffer, B. J., & Boyson, S. J. (1997) · Movement Disorders · doi:10.1002/mds.870120103 · Cited by 69
PARK6-linked autosomal recessive early-onset parkinsonism in Asian populations
Hatano, Y., Sato, K., Elibol, B., Yoshino, H., Yamamura, Y., Bonifati, V., Shinotoh, H., Asahina, M., Kobayashi, S., Ng, A. R., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000142258.29304.fe · Cited by 69
Mizuno, Y., Sone, N., Suzuki, K., & Saitoh, T. (1988) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(88)90010-x · Cited by 66
Hattori, N., Yoshino, H., Tanaka, M., Suzuki, H., & Mizuno, Y. (1998) · Genomics · doi:10.1006/geno.1997.5192 · Cited by 63
Maneb potentiates paraquat neurotoxicity by inducing key Bcl‐2 family members
Fei, Q., & Ethell, D. W. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05293.x · Cited by 61
Value of genetic models in understanding the cause and mechanisms of Parkinson’s disease
Moore, D. J., & Dawson, T. M. (2008) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-008-0045-7 · Cited by 59
Quantitative Proteomics of a Presymptomatic A53T α-Synuclein Drosophila Model of Parkinson Disease
Xun, Z., Sowell, R. A., Kaufman, T. C., & Clemmer, D. E. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700467-mcp200 · Cited by 57
POLG1 in idiopathic Parkinson disease
Tiangyou, W., Hudson, G., Ghezzi, D., Ferrari, G., Zeviani, M., Burn, D. J., & Chinnery, P. F. (2006) · Neurology · doi:10.1212/01.wnl.0000238963.07425.d5 · Cited by 50
Belin, A. C., Björk, B. F., Westerlund, M., Galter, D., Sydow, O., Lind, C., Pernold, K., Rosvall, L., Håkansson, A., Winblad, B., et al. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.05.010 · Cited by 48 · cited 1×
“Recently, mutations/polymorphisms in mitochondrial transcription factor A (TFAM) gene that regulates transcription of mtDNA and copy number has been suspected for its association in PD [101, 102].”
BackgroundOxidative Damage and Fragmentation of Mitochondrial DNA in Cellular Apoptosis
Ozawa, T. (1997) · Bioscience Reports · doi:10.1023/a:1027324410022 · Cited by 47
MITOCHONDRIAL COMPLEX I, II/III, AND IV ACTIVITIES IN FAMILIAL AND SPORADIC PARKINSON'S DISEASE
Hanagasi, H. A., AYRIBAS, D., Baysal, K., & Emre, M. (2005) · International Journal of Neuroscience · doi:10.1080/00207450590523017 · Cited by 46
Characterization of the neuronal dopamine transporter DAT in human blood platelets
Frankhauser, P., Grimmer, Y., Bugert, P., Deuschle, M., Schmidt, M. H., & Schloss, P. D. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.01.062 · Cited by 46
Shinde, S., & PASUPATHY, K. (2006) · Neurology India · doi:10.4103/0028-3886.28112 · Cited by 46
Packer, M. A., Miesel, R., & Murphy, M. P. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)02165-5 · Cited by 45
Swerdlow, R. H., Parks, J. K., Cassarino, D. S., Binder, D. R., Bennett, J. P., Iorio, G. D., Golbe, L. I., & Parker, W. D. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7674 · Cited by 44
Bravi, D., Anderson, J. J., Dagani, F., Davis, T. L., Ferrari, R., Gillespie, M., & Chase, T. N. (1992) · Movement Disorders · doi:10.1002/mds.870070307 · Cited by 43
Taanman, J., & Schapira, A. H. V. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.11.023 · Cited by 41
GRIM-19 associates with the serine protease HtrA2 for promoting cell death
Ma, X., Kalakonda, S., Srinivasula, S. M., Reddy, S. P., Platanias, L. C., & Kalvakolanu, D. V. (2007) · Oncogene · doi:10.1038/sj.onc.1210287 · Cited by 40
Martín, M. A., Molina, J. A., Jiménez-Jiménez, F. J., Benito‐León, J., Pareja, M. O., Campos, Y., Arenas, J., & del Movimiento, T. G. C. D. T. (1996) · Neurology · doi:10.1212/wnl.46.5.1343 · Cited by 39
Bernardi, P., Krauskopf, A., Basso, E., Petronilli, V., Blachly‐Dyson, E., Lisa, F. D., & Forte, M. A. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2006.05297.x · Cited by 39
Aomi, Y., Chen, C.-S., Nakada, K., Ito, S., Isobe, K., Murakami, H., Kuno, S., Tawata, M., Matsuoka, R., Mizusawa, H., et al. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4113 · Cited by 36
Yang, H., Zhou, H., Li, B., Niu, G., & Chen, S. (2007) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-007-9082-2 · Cited by 32
Mitochondrial transcription factor A (TFAM) gene variation in Parkinson's disease
Álvarez, V., Corao, A. I., Sánchez-Ferrero, E., de Mena, L., Alonso‐Montes, C., Huerta, C., Estrada, M. B., Ribacoba, R., Guisasola, L. M., Salvador, C., et al. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2007.12.010 · Cited by 32
Mitochondrial genotypes and cytochrome b variants associated with longevity or Parkinson's disease
Tanaka, M. (2002) · Journal of Neurology · doi:10.1007/s00415-002-1203-5 · Cited by 29
Reichmann, H., Janetzky, B., Bischof, F., et al. (2008) · European Neurology · doi:10.1159/000117053 · Cited by 25
Promethazine protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity
Cléren, C., Starkov, A. A., Calingasan, N. Y., Lorenzo, B. J., Chen, J., & Beal, M. F. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.05.022 · Cited by 23
Self-citationInteraction of 1-methyl-4-phenylpyridinium ion with human platelets
Buckman, T. D., Chang, R., Sutphin, M. S., & Eiduson, S. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80366-8 · Cited by 18
Epidemiology of Parkinson's Disease: An Updated Overview
Oukhrib, M., Tamegart, L., Ghachi, H. E., Maloui, A. B., El‐Mansoury, B., Chraa, M., & Gamrani, H. (2023) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-6684-5156-4.ch001 · Cited by 12
(2000) · doi:10.1002/1531-8249(200011)48:5<730::aid-ana6>3.0.co;2-0
Cited by
Cellular Stress Responses: Cell Survival and Cell Death
Fulda, S., Gorman, A. M., Hori, O., & Samali, A. (2010) · International Journal of Cell Biology · doi:10.1155/2010/214074 · Cited by 1,519
Genetic Animal Models of Parkinson's Disease
Dawson, T. M., Ko, H. S., & Dawson, V. L. (2010) · Neuron · doi:10.1016/j.neuron.2010.04.034 · Cited by 823
Saxena, S., & Caroni, P. (2011) · Neuron · doi:10.1016/j.neuron.2011.06.031 · Cited by 572
Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases
(2018) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2018.05.006 · Cited by 455
Neuropathology of sporadic Parkinson's disease: Evaluation and changes of concepts
Jellinger, K. A. (2012) · Movement Disorders · doi:10.1002/mds.23795 · Cited by 451
Metadata
- Authors
- Banerjee, R., Starkov, A. A., Beal, M. F., & Thomas, B.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Publisher
- Elsevier BV
- Published
- 2009-07
- Volume
- 1792
- Issue
- 7
- Pages
- 651-663
- ISSN
- 0925-4439 (ISSN-L)
- OpenAlex
- W2119765154
- Cited by
- 253
- References
- 232
- FWCI
- 16.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.